Current evidence highlights vitamin E's role in managing oxidative stress in non-alcoholic fatty liver disease, suggesting a potential treatment approach.
Non-alcoholic fatty liver disease (NAFLD), recently reclassified as metabolic dysfunction-associated steatotic liver disease (MASLD), encompasses a spectrum from simple steatosis to non-alcoholic steatohepatitis (NASH), fibrosis, cirrhosis, and hepatocellular carcinoma. It is strongly associated with metabolic syndrome, obesity, and insulin resistance.
No takes yet. Share an insight, caveat, or question.
1*Shaik Ahammad, 1J. M. V. Lakshmi, 1Panchananam Lekhana, 2Dr. T. Sharath Babu (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: